what does the fda hope to achieve through developing the rare disease cures accelerator?
Published 3 years ago • 84 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
57:07
what you need to know about the rare disease cures accelerator-data and analytics platform
-
31:11
from data to cures: speeding the way for rare diseases
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
8:12
fda approves bkemv, the first interchangeable biosimilar for two rare diseases!
-
7:40
aortitis - paths to the problem
-
2:54
respeecher revives communication capabilities for a patient with friedreich's ataxia
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
4:07
what is exciting to you about taking on this ambitious project?
-
1:51
rare disease patient voice: justin moy
-
46:37
clinical trial simulation tools advancing treatments in rare disease
-
5:18
what is exciting to you about taking on this ambitious project?
-
2:11
research; making a rare impact
-
8:10
do you think the community will work together to share data, or do you anticipate resistance?
-
11:08
rare disease endpoint advancement rdea pilot program
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
2:06
rare disease patient voice: kelly barendt
-
1:34
dr. janet maynard recognizes successes and continued need for rare disease research grants